Generic Form of Actos Approved by the FDA

October 26, 2012

Diabetics Still At Risk When Taking Actos in its Generic Form

At the close of the summer this year, the FDA approved the first generic form of Actos, a prescription medication for those with Type 2 diabetes.  However, both Actos and its generic version, Pioglitazone Hydrochloride, can worsen or cause heart failure, in addition to increasing one's risk for bladder cancer after the use of this drug for over one year.  Although the FDA recently mandated the drug manufacturers warn patients of these increased risks, for many the warnings have come after the damage has already been done.

Waves of recent studies repeatedly confirm that this type of diabetes medication can be hazardous to one's health. Despite the increased availability of Actos in a generic form, Consumer R reports just issued a report advising one should avoid this drug unless other options are unavailable. For more information on these studies and the history of this drug, please see our Actos Law Office website related to the dangers of Actos.

As of this year, hundreds of lawsuits have been filed nationwide and the litigation related to this drug is expected to continue to grow. Several federal cases have been consolidated into Multi-District litigation in the U.S. District Court for the Western District of Louisiana, while numerous cases are also gathering momentum at a state level. The plaintiffs in these cases request compensation for medical expenses, lost wages, and pain and suffering, as a result of the manufacturer's failure to promptly warn of the dangers related to this drug. If you have been developed heart failure or bladder cancer while taking Actos, please do not hesitate to contact our law offices for a free legal consultation.  For more information concerning your legal rights, contact the Law Offices of Padilla Law Group, LLP. 858.481.5454.